BRCA2 and breast carcinoma: In a 33‐year‐old Italian breast cancer patient belonging to a HBOC family (BRCAPro score: 88%) with no other known pathogenic BRCA mutation, we identified a novel c.682‐2delA variant involving the AG consensus at the 3′ end of BRCA2 intron 8 (Figure 1a).